Public research footprint of Università degli Studi di Messina, compiled from the ClinicalTrials.gov public registry.
Pompe Disease (Late-onset) · Pseudo Hypoparathyroidism · Glycogen Storage Disease Type 2 · End Stage Kidney Disease
Enter your work email to view the full list.
Verify and correct how your facility appears in public registry records — free.
Verify this profile →Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.